Stay updated on Tiragolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked. The surrounding site chrome remains, but the study content is replaced by an access-denied message.SummaryDifference17%

- Check40 days agoChange DetectedPublications section added, including the SKYSCRAPER-01 JCO publication citation and a note that publications are automatically filled from PubMed. This provides updated scholarly context for the study record.SummaryDifference0.1%

- Check47 days agoChange DetectedNIH grant/contract notation was added under the study identifiers. The page revision now shows v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study's results status updated from 'No Results Posted' to 'Results Submitted', indicating that the results have been submitted for posting and will move toward public availability.SummaryDifference0.0%

- Check69 days agoChange DetectedA new revision label v3.6.5 was added and the previous v3.6.4 label was removed, indicating an updated page version without changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Tiragolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.